Omnicell Investor Presentation Deck slide image

Omnicell Investor Presentation Deck

© 2023 Omnicell, Inc. Reconciliation of GAAP income from operations to non-GAAP income from operations: GAAP income from operations Omnicell, Inc. Reconciliation of GAAP to Non-GAAP (Unaudited, in thousands, except per share data and percentage) GAAP operating income % to total revenues Share-based compensation expense Amortization of acquired intangibles Acquisition accounting impact related to deferred revenues Acquisition-related expenses Impairment and abandonment of operating lease right-of-use and other assets related to facilities Ransomware-related expenses, net of insurance recoveries Executives transition costs Severance-related and other expenses, net of reversals (d) Non-GAAP income from operations Non-GAAP operating margin (non-GAAP operating income as a % of total non-GAAP revenues) Reconciliation of GAAP net income to non-GAAP net income: GAAP net income Share-based compensation expense Amortization of acquired intangibles Acquisition accounting impact related to deferred revenues. (a) (d) Acquisition-related expenses Impairment and abandonment of operating lease right-of-use and other assets related to facilities Ransomware-related expenses, net of insurance recoveries Tax effect of the adjustments above (¹) Non-GAAP net income Executives transition costs Severance-related and other expenses, net of reversals (d) Amortization of debt issuance costs $ $ $ $ Three Months Ended September 30, 2023 1.2% 9.1% 3,712 $ 14,982 7,683 246 (184) 1,348 (581) 27,206 $ 5,553 $ 14,982 7,683 246 (184) 1,348 (581) 1,048 (2,008) 28,087 $ 2022 5.3% 14.0% 18,465 17,310 8,745 183 251 297 1,027 2,494 48,772 16,774 17,310 8,745 183 251 297 1,027 2,494 1,042 (2,948) 45,175 Tax effects calculated for all adjustments except share-based compensation expense, using an estimated annual effective tax rate of 21% for both fiscal years 2023 and 2022. For the three months ended September 30, 2022, other expenses included approximately $0.7 million of certain litigation expenses. 23
View entire presentation